Pages that link to "Q34604140"
Jump to navigation
Jump to search
The following pages link to Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function (Q34604140):
Displaying 50 items.
- An update on antibody-based immunotherapies for Clostridium difficile infection (Q26740788) (← links)
- Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects (Q26751477) (← links)
- The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins (Q26775010) (← links)
- Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis (Q26777157) (← links)
- WSES guidelines for management of Clostridium difficile infection in surgical patients (Q26795429) (← links)
- Clostridium difficile infection: molecular pathogenesis and novel therapeutics (Q26864237) (← links)
- Calcium-sensing receptors signal constitutive macropinocytosis and facilitate the uptake of NOD2 ligands in macrophages (Q27320060) (← links)
- Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase (Q27658750) (← links)
- Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity (Q27676848) (← links)
- Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile (Q27680788) (← links)
- The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release (Q27681638) (← links)
- Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain (Q28302768) (← links)
- Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins (Q28743234) (← links)
- Clostridium difficile infection: new developments in epidemiology and pathogenesis (Q29615330) (← links)
- The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis (Q30411888) (← links)
- Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells (Q30439237) (← links)
- Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity (Q33584866) (← links)
- Quantitative mass spectrometry for bacterial protein toxins--a sensitive, specific, high-throughput tool for detection and diagnosis. (Q33845862) (← links)
- Clostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2. (Q33860004) (← links)
- Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. (Q33936336) (← links)
- The HtrA-like protease CD3284 modulates virulence of Clostridium difficile (Q34298746) (← links)
- Comparative nutritional and chemical phenome of Clostridium difficile isolates determined using phenotype microarrays (Q34339043) (← links)
- The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection (Q34623572) (← links)
- Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients (Q34624447) (← links)
- Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death (Q34740081) (← links)
- Fecal transplant policy and legislation (Q34827720) (← links)
- Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and B (Q35075772) (← links)
- Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives (Q35155775) (← links)
- Evaluation of a focused virtual library of heterobifunctional ligands for Clostridium difficile toxins (Q35390804) (← links)
- Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile (Q35536689) (← links)
- Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease (Q35621057) (← links)
- Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli (Q35925409) (← links)
- Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling (Q36041225) (← links)
- Toward a structural understanding of Clostridium difficile toxins A and B. (Q36159563) (← links)
- Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen (Q36190012) (← links)
- The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? (Q36515597) (← links)
- Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities (Q36631348) (← links)
- A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity (Q36662134) (← links)
- The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge (Q36889259) (← links)
- Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse mo (Q36911461) (← links)
- Protective efficacy induced by recombinant Clostridium difficile toxin fragments (Q37036112) (← links)
- Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? (Q37287190) (← links)
- Regulation of smooth muscle contraction by small GTPases (Q37649264) (← links)
- Emerging therapies forClostridium difficileinfections (Q37858531) (← links)
- Super toxins from a super bug: structure and function of Clostridium difficile toxins. (Q37880148) (← links)
- Toxins-useful biochemical tools for leukocyte research (Q37954284) (← links)
- The enterotoxicity of Clostridium difficile toxins (Q37954308) (← links)
- Novel management strategies in the treatment of severe Clostridium difficile infection. (Q38032858) (← links)
- Molecular basis of early stages of Clostridium difficile infection: germination and colonization (Q38036703) (← links)
- Vaccines against Clostridium difficile (Q38196682) (← links)